Hepatitis B Vaccine Market Growth, Trends, and Forecast 2025 | Top key players - Merck & Co., Inc, Sanofi, GlaxoSmithKline plc | US Tariff Effects

The Global Hepatitis B Vaccine Market reached USD 4.3 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 6.1 billion by 2030. The global hepatitis B vaccine market is expected to exhibit a CAGR of 4.6% during the forecast period (2024-2031).

Hepatitis B Vaccine Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/hepatitis-b-vaccine-market?sz

The Hepatitis B Vaccine Market involves the development, production, and distribution of vaccines designed to prevent Hepatitis B infection, a serious liver disease caused by the Hepatitis B virus (HBV). These vaccines are typically administered in multiple doses to infants, children, and high-risk adults. The market is driven by increasing awareness, government vaccination programs, and rising Hepatitis B cases globally.

List of the Key Players in the Hepatitis B Vaccine Market:

Merck & Co., Inc, Sanofi, GlaxoSmithKline plc, Indian Immunologicals Limited, LG Chem, KM Biologics, Dynavax Technologies, Bharat Biotech, Serum Institute of India Pvt. Ltd, and Biological E Limited among Others.

Industry Development:

In December 2022, VBI Vaccines Inc., a biopharmaceutical company focused on immunology, announced that PreHevbrio 3-antigen Hepatitis B Vaccine (Recombinant) received approval from Health Canada for the active immunization against hepatitis B (HBV) virus infection. This vaccine is now authorized for use in adults aged 18 years and older, providing protection against all known subtypes of HBV, marking a significant advancement in hepatitis B prevention.

In February 2023, HEPLISAV B, a two-dose adult Hepatitis B adjuvanted vaccine, was granted marketing approval by the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom. The vaccine, developed by Dynavax, was authorized for the active immunization against hepatitis B virus (HBV) infection in adults aged 18 years and older, covering all known subtypes of HBV, thus enhancing the availability of effective vaccines for hepatitis B prevention in the UK.

Assessing the Effects of U.S. Tariffs on the Market

The U.S. tariff war is reshaping how businesses analyze trends and make strategic decisions. As tariffs drive up costs and disrupt supply chains, companies are increasingly focused on understanding consumer behavior, identifying new sourcing opportunities, and adjusting their operations to remain competitive. The ongoing uncertainty has created a stronger demand for timely insights and data-driven strategies to navigate shifting trade dynamics and economic pressures.

Research Process:

Both primary and secondary data sources have been used in the global Hepatitis B Vaccine Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/hepatitis-b-vaccine-market

Segment Covered in the Hepatitis B Vaccine Market:

By Type: Combination Vaccines, Single Antigen Vaccine.

By End-User: Hospitals, Clinics, Vaccination Centre, Others.

Regional Analysis for Hepatitis B Vaccine Market:

The regional analysis of the Hepatitis B Vaccine Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/hepatitis-b-vaccine-market

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Hepatitis B Vaccine market?

➠ Who are the leading manufacturers in the global Hepatitis B Vaccine industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Hepatitis B Vaccine industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Hepatitis B Vaccine market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/hepatitis-b-vaccine-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.